Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
41,795 results
  • Surgery for Dysphagia Lusoria in Children. [Journal Article]
  • ATAnn Thorac Surg 2019 Jul 10
  • Nelson JS, Hurtado CG, Wearden PD
  • Aberrant right subclavian artery, or arteria lusoria, is a common congenital anomaly of the aortic arch and may be associated with dysphagia. Surgical treatment, particularly in children, remains con…
  • Can cell-free DNA testing be used in pregnancies with increased nuchal translucency? [Journal Article]
  • UOUltrasound Obstet Gynecol 2019 Jul 13
  • Miranda J, Paz Y Miño F, … Borrell A
  • CONCLUSIONS: cfDNA does not appear to be the appropriate genetic test in fetuses with a NT above the 99th centile, given that 12-19% of the genetic anomalies were undetectable with the current tests. Additionally, 6.6% of fetuses will have a major structural abnormality identifiable using first-trimester ultrasound. This article is protected by copyright. All rights reserved.
  • Use of Tubular Retractors for Minimally Invasive Resection of Deep-Seated Cavernomas. [Journal Article]
  • ONOper Neurosurg (Hagerstown) 2019 Jul 13
  • Eichberg DG, Di L, … Starke RM
  • CONCLUSIONS: Tubular retractors provide a low-profile, minimally invasive operative corridor for resection of subcortical cavernomas. There were no permanent neurologic complications in our series of 20 cases, and long-term seizure control was achieved in all patients. Thus, tubular retractors appear to be a safe and efficacious tool for resection of subcortical cavernomas.
  • Hypospadias Prevalence and Trends in International Birth Defect Surveillance Systems, 1980-2010. [Journal Article]
  • EUEur Urol 2019 Jul 09
  • Yu X, Nassar N, … Agopian AJ
  • CONCLUSIONS: The international total prevalence of hypospadias for all years was 20.9 (95% confidence interval: 19.2-22.6) per 10000 births. The prevalence for each program ranged from 2.1 to 39.1 per 10000 births. The international total prevalence increased 1.6 times during the study period, by 0.25 cases per 10000 births per year (p<0.05). When analyzed separately, there were increasing trends for first-, second-, and third-degree hypospadias during the early 1990s to mid-2000s. The majority of programs (61.9%) had a significantly increasing trend during many of the years evaluated. Limitations include known differences in data collection methods across programs.Although there have been changes in clinical practice and registry ascertainment over time in some countries, the consistency in the observed increasing trends across many programs and by degrees of severity suggests that the total prevalence of hypospadias may be increasing in many countries. This observation is contrary to some previous reports that suggested that the total prevalence of hypospadias was no longer increasing in recent decades.
New Search Next